ZIVO Bioscience (NASDAQ:ZIVOW) Stock Price Up 13%
ZIVO Bioscience (NASDAQ:ZIVOW) Stock Price Up 13%
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) rose 13% during trading on Wednesday . The stock traded as high as $0.85 and last traded at $0.80. Approximately 7,468 shares traded hands during trading, an increase of 191% from the average daily volume of 2,563 shares. The stock had previously closed at $0.71.
ZIVO Bioscience, Inc.（纳斯达克股票代码：ZIVOW — 获取评级）在周三的交易中上涨了13％。该股的交易价格高达0.85美元，最后一次交易价格为0.80美元。交易期间约有7,468股股票交易，较平均每日交易量2,563股增长了191％。该股此前收于0.71美元。
ZIVO Bioscience Stock Performance
ZIVO 生物科学股票表现
The firm's 50 day simple moving average is $0.73 and its 200 day simple moving average is $0.78.
该公司的50天简单移动平均线为0.73美元，其200天简单移动平均线为0.78美元。
Institutional Inflows and Outflows
机构流入和流出
A hedge fund recently raised its stake in ZIVO Bioscience stock. Warberg Asset Management LLC boosted its position in shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,654 shares of the company's stock after buying an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 as of its most recent filing with the Securities & Exchange Commission.
一家对冲基金最近提高了其在ZIVO Bioscience股票的股份。根据Warberg Asset Management LLC向美国证券交易委员会披露的最新信息，华伯格资产管理有限责任公司在第三季度将其在ZIVO Bioscience, Inc.（纳斯达克股票代码：ZIVOW — Get Rating）的股票头寸提高了442.0％。该公司在本季度又购买了69,034股股票后，拥有该公司的84,654股股票。截至最近向美国证券交易委员会提交的文件，Warberg Asset Management LLC在ZIVO Bioscience的持股价值51,000美元。
About ZIVO Bioscience
关于 ZIVO 生物科学
(Get Rating)
（获取评分）
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc是一家总部位于密歇根州的生物技术/农业科技公司，致力于利用其专有藻类培养物衍生的生物活性化合物的免疫健康和营养益处。该开发产品包括用作膳食补充剂和功能性食品原料的天然产品，以及旨在为人类和动物提供药用和药物益处的创新、生物衍生和合成的候选产品，特别侧重于调节免疫和炎症反应。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Roblox Gains Traction With Metaverse, Shares Pop
- GXO Logistics Manages Another Buying Opportunity
- Arista Networks In Buy Range After Topping Q4 Views
- Analysts Like The Flavor Of Restaurant Brands International
- What is Consumer Discretionary?
- 免费获取 StockNews.com 关于 ZIVO Bioscience (ZIVOW) 的研究报告
- Roblox 通过元界获得关注，股价暴涨
- GXO Logistics 管理着另一个购买机会
- Arista Networks 在突破第四季度浏览量后进入买入区间
- 像国际餐厅品牌之味这样的分析师
- 什么是消费者自由裁量权？
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收《ZIVO 生物科学日报》的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收ZIVO Bioscience及相关公司的最新新闻和分析师评级的简明每日摘要。